Zentalis Pharmaceuticals, Inc. (ZNTL) Shareholders’ equity 2022–2025
Zentalis Pharmaceuticals, Inc. (ZNTL) shareholders’ equity at each fiscal year-end, per SEC filings.
$216.2MFY2025 · since FY2022: $433.8M → $216.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $216.2M | -35.9% |
| FY2024 | $337.2M | -22.9% |
| FY2023 | $437.3M | +0.8% |
| FY2022 | $433.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice